Stefano PEPE | Publications
Stefano PEPE Publications
| 2008 | |
| Abstract in rivista | |
| Predictive factors of response to neoadjuvant chemoradiotherapy in rectal cancer patirnts. ANNALS OF ONCOLOGY. Vol. 19. Pag.74-74 ISSN:0923-7534. | |
| C., Carlomagno; F., D'Armiento; A., Crispo; G., Della Vittoria Scarpati; M., D'Armiento; M., Marra; L., Cannella; A., De Stefano; M., Colantuoni; S., Alfieri; S., De Placido; Pepe, Stefano | |
| Show it in Product Database (IRIS) |
| 2008 | |
| Abstract in rivista | |
| Phase I-II study of sequential combination of XELOX and bevacizumab plus erlotinib (XELOX-TARAV) in first line colorectal patients:Run in phase I part ANNALS OF ONCOLOGY. Vol. 19. Pag.100-101 ISSN:0923-7534. | |
| C., Carlomagno; R., Bianco; G., Daniele; R., Marciano; Pepe, Stefano; V., Adamo; F., Ciardiello; S., De Placido; G., Tortora | |
| Show it in Product Database (IRIS) |
| 2008 | |
| Abstract in rivista | |
| XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES CYTOMETRY. PART A. Vol. 73A. Pag.60-60 ISSN:1552-4922. | |
| Fusciello, C; Bolognese, A; La Vecchia, A; Ubezio, P; Sabbatino, F; Pepe, S | |
| Digital Object Identifier (DOI): 10.1002/cyto.a.20493 | |
| Show it in Product Database (IRIS) |
